Drug delivery device
By designing a drug delivery device with exhaust, injection and unloading components, the problem of inaccurate injection of viscous liquids in the prior art is solved, and accurate dosing of eye liquids is achieved, and the injection accuracy is improved. and convenience of use.
Patent Information
- Application Number
- CN202323554943.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Priority Date
- 2022-12-30
- Filing Date
- 2023-12-25
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2033-12-25
AI Technical Summary
Existing ocular drug delivery devices are difficult to achieve accurate quantitative dosing of viscous drug liquids, especially in small doses, which leads to inaccurate drug injections, affecting the treatment effect and patient safety.
A drug delivery device is designed, including a housing, cartridge, push rod, exhaust assembly, injection assembly and unloading assembly. Through the axial movement and rotation of the push rod, combined with exhaust and injection operations, the precision of the drug is achieved. Inject and prevent drug wakes through the force-release assembly to improve drug delivery accuracy.
It realizes accurate quantitative dosing of viscous drug liquid, improves injection accuracy and convenience of use, reduces the risk of overdose discharge of drugs, and is suitable for high-demand drug delivery needs in the eyes.
Smart Images

Figure CN222032828U_ABST
Abstract
Description
[0001] This application claims priority to Chinese Patent Application No. 202211727431.9, entitled “Drug Delivery Device”, filed on December 30, 2022, and the contents of the Chinese patent application disclosure are hereby cited in their entirety as a part of this application. Technical Field
[0002] The present disclosure relates to drug delivery devices, and in particular to drug delivery devices preloaded with a drug. Background Art
[0003] The eye is one of the most sensitive organs in the human body. The three layers of the eyeball wall from the outside to the inside are the outer membrane (cornea, sclera), the middle membrane (iris, ciliary body and choroid) and the inner membrane (retina). Ocular drug delivery is the main means of ophthalmic treatment. Due to the high sensitivity of the eye and the unique physiological barriers (including corneal and conjunctival barriers, blood-aqueous humor barriers, and blood-retinal barriers), clinical fundus drug delivery is difficult.
[0004] Traditional ocular drug delivery forms are topical eye drops and eye ointments. These two common dosage forms have the advantages of preparing solutions and being easy to use, and are easily accepted by patients. However, eye drops have low bioavailability and short duration of action. Most of the drug solution is discharged from the tear duct after administration, and may cause systemic toxicity after absorption through the nose and pharynx; the transparency and refractive index of the matrix contained in the ointment can easily cause patients to have foggy vision. In order to achieve the drug delivery dose at the back of the eye, subconjunctival, peribulbar, and retrobulbar injections began to be used clinically in the early 20th century. This type of drug delivery is the most direct method to deliver drugs to the tissues at the back of the eye, which can quickly accumulate drugs near the retina and vitreous body. The drug concentration in the tissues at the back of the eye can reach a high level, with rapid onset, few side effects, and little impact on the whole body. It is currently mainly used to treat age-related macular degeneration (AMD), retinal vein occlusion (RVO), diabetic eye disease, posterior uveitis and other diseases.
[0005] The volume of the human eyeball is about 5ml, of which the anterior chamber is about 0.5ml and the posterior chamber is about 4.5ml. In addition to considering the therapeutic effect of the drug and the injection site when administering drugs to the fundus, micro-precision administration is also a key issue of concern. The larger the volume of fundus administration, the greater the impact on intraocular pressure and the greater the damage to the eyeball. When administering drugs in small volumes, the accuracy of the drug dosage is difficult to achieve using conventional syringes. For example, the products commonly used for fundus administration are currently solid implants and liquid injections. Among them, solid implants are solid drugs that are injected directly into the eye through the sclera, which is very harmful to the eyeball; liquid preparations usually have a dosage of 50 microliters, which can be directly administered by drawing them directly with a conventional syringe. For aqueous solutions with a dosage of less than 25 microliters, especially for viscous liquid medicines, the accuracy of fundus administration dosage is difficult to achieve using conventional syringes.
[0006] Therefore, in clinical applications, a drug delivery device is needed that can accurately and quantitatively administer drugs, especially for the accurate and quantitative administration of viscous drug solutions. In particular, an ocular drug delivery device that can meet the high requirements of the eye is needed. Utility Model Content
[0007] The technical problem to be solved by the utility model is to provide a drug delivery device, which can administer drugs more accurately and quantitatively, and can be used for eye delivery, and can deliver viscous drug liquids more accurately and quantitatively.
[0008] At least one embodiment of the utility model provides a drug delivery device, comprising: a shell; a cartridge, which is arranged in the shell and has a hollow containing space for loading a drug; a push rod, which includes a push rod distal end and a push rod proximal end, the push rod distal end is accommodated in the hollow containing space of the cartridge and can move relative to the cartridge in an axial direction; an exhaust assembly, which is configured to cause the push rod to move distally relative to the cartridge in an axial direction, the exhaust assembly includes an exhaust button, and the exhaust button is installed at the proximal end of the push rod; an injection assembly, which is configured to cause the push rod to move distally relative to the cartridge in an axial direction, the injection assembly includes an injection spring and a trigger button, the injection spring is installed on the push rod, and the trigger button is arranged at the outer peripheral wall of the shell; and a force unloading assembly, which is configured to cause the push rod to move in a proximal direction opposite to the distal direction after the push rod is moved distally by the exhaust assembly and / or the injection assembly.
[0009] In the above embodiment, the exhaust assembly causes the push rod to move distally to exhaust air, and then the unloading assembly can cause the push rod to retract proximally. Additionally or alternatively, the injection assembly causes the push rod to move distally to inject the drug, and then the unloading assembly can cause the push rod to retract proximally. Since the push rod retracts proximally after moving distally, it is prevented that the drug is discharged from the cartridge during exhaust and / or more than the expected dose. Therefore, the injection accuracy is improved, especially for drugs with high viscosity.
[0010] For example, in some embodiments, the exhaust button is configured to drive the push rod to move distally in an axial direction relative to the cartridge through a first movement.
[0011] For example, in some embodiments, the exhaust button is further configured to allow the push rod to move proximally relative to the cartridge through a second movement after the first movement. The unloading assembly includes a first unloading assembly, which is configured to cause the push rod to move proximally relative to the cartridge during the second movement of the exhaust button.
[0012] In the above embodiment, the user can manipulate the exhaust button to perform the first movement and the second movement to control the push rod to move distally and proximally respectively, thereby achieving exhaust and force release after exhaust. Therefore, the operability of the drug delivery device is improved.
[0013] For example, in some embodiments, the first movement of the vent button is a distal axial movement.
[0014] For example, in some embodiments, the second motion of the vent button is a rotation about the longitudinal axis and a proximal axial movement.
[0015] By configuring the first movement as a distal axial movement and / or configuring the second movement as a rotation about the longitudinal axis and a proximal axial movement, operability and convenience for the user are improved.
[0016] For example, in some embodiments, the injection spring is configured to be compressed in response to the first movement of the exhaust button. The trigger button is configured to be actuated to release the energy stored in the injection spring due to compression, causing the push rod to move distally to discharge the drug in the hollow receiving space.
[0017] Since the injection spring and the trigger button are provided, the injection operation of discharging the medicine in the hollow accommodation space can be started by actuating the trigger button by means of the energy stored in the injection spring, thereby improving the operability and convenience of the user.
[0018] For example, in some embodiments, the drug delivery device further comprises a sliding ejector configured to releasably restrict distal movement of the push rod, and the restriction is releasable by actuation of a trigger button.
[0019] For example, in some embodiments, the push rod is driven by the exhaust button to move distally, thereby moving the sliding ejector distally, and the distal movement of the sliding ejector causes the firing button to abut against the sliding ejector distally.
[0020] For example, in some embodiments, the drug delivery device further comprises a retaining element which is at least partially fitted within the vent button to move distally together with the vent button during the first movement of the vent button and compress the injection spring.
[0021] For example, in some embodiments, the housing has a first housing stopper protruding inwardly. The retaining element has a second elastic arm extending proximally. After the first movement of the exhaust button, the second elastic arm moves from the proximal side of the first housing stopper to the distal side of the first housing stopper by deformation, so that the first housing stopper limits the movement of the retaining element proximally.
[0022] For example, in some embodiments, the push rod proximal end of the push rod is inserted into the exhaust button. The push rod also includes a radial flange arranged between the push rod proximal end and the push rod distal end, and the injection spring abuts between the proximal end surface of the radial flange and the retaining element.
[0023] For example, in some embodiments, the push rod is further formed with at least one push rod arm protruding radially on the distal side of the radial flange, the sliding ejection member has a pushing surface, and the push rod arm abuts against the pushing surface of the sliding ejection member.
[0024] For example, in some embodiments, the exhaust button is further configured to allow the push rod to move proximally relative to the cartridge by a second movement after the first movement. The unloading assembly includes a first unloading assembly, which is configured to cause the push rod to move proximally relative to the cartridge during the second movement of the exhaust button. The first unloading assembly includes a push surface and a push rod arm of the sliding ejection member, and the second movement of the exhaust button causes the push rod to rotate, thereby causing the push rod arm to slide on the push surface, and the push surface is formed so that the push rod arm slides on the push surface to cause the push rod to move proximally relative to the cartridge.
[0025] For example, in some embodiments, the pushing surface is formed as a slope inclined in the circumferential direction or a spirally ascending slope.
[0026] For example, in some embodiments, the second movement of the exhaust button includes a rotation around the longitudinal axis in the unloading rotation direction. The proximal end of the push rod is matched with the exhaust button in shape, so that the push rod can move in the axial direction relative to the exhaust button, but cannot rotate relatively, so that when the exhaust button rotates, the push rod is driven to rotate together.
[0027] For example, in some embodiments, the second movement of the exhaust button also includes axial movement toward the proximal side. The retaining element includes a retaining element body, on the outer peripheral surface of which a matching recess extending in a spiral shape is provided. The exhaust button has a cylindrical wall, and a matching protrusion is provided on the inner side surface. The retaining element body is assembled in the cylindrical wall of the exhaust button so that the matching protrusion is accommodated in the matching recess to allow the exhaust button to be able to move axially relative to the retaining element while rotating relative to the retaining element.
[0028] For example, in some embodiments, the housing has a third housing stopper protruding inward. The exhaust button has a third elastic arm extending circumferentially in a direction opposite to the unloading rotation direction. After the second movement of the exhaust button, the third elastic arm passes over the third housing stopper in the circumferential direction, so that the third housing stopper prevents the exhaust button from rotating back.
[0029] For example, in some embodiments, the exhaust button further includes a guide protrusion extending in the axial direction and an avoidance notch on the proximal side of the guide protrusion. The third housing limit portion extends in the axial direction and protrudes inward. The housing further includes: a fourth housing limit portion extending in the axial direction and protruding inward, and a fifth housing limit portion protruding inwardly spaced circumferentially from the third and fourth housing limit portions in the unloading rotation direction. The third housing limit portion extends distally in the axial direction beyond the fourth housing limit portion and is opposite and spaced in the circumferential direction from the fourth housing limit portion in the direction opposite to the unloading rotation direction to define a propulsion guide groove. Before the first movement of the exhaust button, the guide protrusion of the exhaust button can be axially slidably arranged in the propulsion guide groove so that the exhaust button cannot be rotated. After the first movement of the exhaust button, the avoidance notch of the exhaust button is aligned with the fourth housing limit portion in the circumferential direction, and the guide protrusion of the exhaust button is aligned with the third housing limit portion in the circumferential direction, so that the exhaust button can only rotate in the unloading rotation direction but cannot rotate in the opposite direction. The fifth housing limiting portion is located in the force-releasing rotation direction of the guide protrusion to prevent the guide protrusion from further rotating in the force-releasing rotation direction after the second movement of the exhaust button.
[0030] For example, in some embodiments, the unloading assembly includes a second unloading assembly configured to be actuated in response to the push rod being moved distally by the injection assembly until the injection is completed, thereby causing the push rod to move proximally relative to the cartridge.
[0031] For example, in some embodiments, the unloading assembly includes a second unloading assembly, which is configured to be actuated in response to the push rod being moved distally by the injection assembly until the injection is completed, so that the push rod moves proximally relative to the cartridge. The second unloading assembly includes an unloading ring sleeved on the sliding ejection member, an unloading spring for biasing the unloading ring proximally, and a first elastic arm extending distally of the retaining element, wherein the first elastic arm is releasably pressed against the unloading ring from the distal side to block the unloading ring from moving proximally.
[0032] For example, in some embodiments, the push rod is moved distally by the injection assembly so that the first elastic arm releases the obstruction of the unloading ring, allowing the unloading ring to move proximally under the action of the unloading spring, and thereby the unloading ring pushes the push rod to move proximally.
[0033] For example, in some embodiments, the push rod is also formed with a radially protruding push rod arm at the distal side of the radial flange. During the push rod is moved distally by the injection assembly, the push rod arm causes the first elastic arm to be laterally offset to release the blocking of the unloading ring.
[0034] For example, in some embodiments, the unloading ring includes a stopper extending proximally, and the first resilient arm releasably abuts against the stopper of the unloading ring from the distal side.
[0035] For example, in some embodiments, the blocking portion is formed in a step shape.
[0036] For example, in some embodiments, when the retaining element moves distally during the first movement of the exhaust button, the unloading ring moves distally via the first resilient arm to compress the unloading spring.
[0037] One or more combinations of the configurations of the elements in the drug delivery device in the above embodiments make the drug delivery device compact and simple in structure, and enable the drug delivery device to reliably achieve accurate drug delivery operations including force-releasing operations. BRIEF DESCRIPTION OF THE DRAWINGS
[0038] In order to more clearly illustrate the technical solutions of the embodiments of the present disclosure, the drawings required for use in the embodiments will be briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present disclosure and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without paying creative work.
[0039] Figure 1 shows a longitudinal cross-sectional view of a drug delivery device according to an embodiment of the present disclosure, wherein a needle replacement element is mounted on a cartridge;
[0040] Figure 2 Shows Figure 1 Another longitudinal cross-sectional reference view of a drug delivery device, wherein the needle replacement element is replaced with a needle;
[0041] Figure 3 Shows Figure 1 An exploded perspective view of a drug delivery device;
[0042] Figure 4 Shows Figure 1 A perspective view of the push rod of the drug delivery device shown;
[0043] Figure 5A and Figure 5B They are shown respectively Figure 1 A perspective view of the exhaust button of the drug delivery device shown;
[0044] Figure 6 Shows Figure 1 A perspective view of the retaining element of the drug delivery device shown;
[0045] Figure 7 Shows Figure 1 A perspective view of the exhaust button of the drug delivery device and a retaining element assembled to the exhaust button;
[0046] Figure 8 Shows Figure 1 A perspective view of a sliding ejector of a drug delivery device shown;
[0047] Fig. 9 Shows Figure 1 A perspective view of the force-relieving ring of the drug delivery device shown;
[0048] Fig.10 Shows Figure 1 A three-dimensional view of the sliding ejection member of the drug delivery device and the unloading ring assembled to the sliding ejection member 9;
[0049] Fig.11 Shows Figure 1 A perspective view of a trigger button of a drug delivery device is shown;
[0050] Fig. 12A and Fig. 12B They are shown respectively Figure 1 A perspective view of the first half shell and the second half shell of the drug delivery device shown;
[0051] Figure 13-16B They are shown respectively Figure 1 Another longitudinal cross-sectional view of the drug delivery device shown, wherein Fig.13 The push rod of the drug delivery device is in the exhaust position. Fig.14 The push rod of the drug delivery device is in the first force-releasing position, Fig.15A and Fig. 15B The push rod of the drug delivery device in the embodiment is in the drug delivery position, and Fig.16A and Fig. 16B The push rod of the drug delivery device is in a second force-releasing position;
[0052] Fig.17 Shows Figure 1 A perspective view of the drug delivery device shown, wherein the push rod is in the exhaust position;
[0053] Fig.18 Shows Fig.17 A partial enlarged view of
[0054] Fig.19 Shows Figure 1 A longitudinal cross-sectional reference view of the drug delivery device shown, wherein the push rod is in a first unloading position;
[0055] Fig. 20 Shows Fig.19 A partial enlarged view of
[0056] Fig.21 A view taken at the guide protrusion of the exhaust button before the exhaust button is pressed is shown. Figure 1 A transverse cross-sectional reference view of the drug delivery device shown;
[0057] Fig. 22A view taken at the guide protrusion of the exhaust button after pressing the exhaust button and before rotating the exhaust button is shown. Figure 1 A transverse cross-sectional view of the drug delivery device shown; and
[0058] Fig.23 A view taken at the guide protrusion of the exhaust button after the exhaust button is rotated is shown. Figure 1 A transverse cross-sectional view of the drug delivery device is shown. DETAILED DESCRIPTION
[0059] Below, the drug delivery device according to the embodiment of the present disclosure is described in detail with reference to the accompanying drawings. In order to make the purpose, technical solution and advantages of the present utility model more clear, the technical solution in the embodiment of the present disclosure will be clearly and completely described below in conjunction with the accompanying drawings in the embodiment of the present disclosure. Obviously, the described embodiment is a part of the embodiment of the present disclosure, not all of the embodiments.
[0060] Therefore, the following detailed description of the embodiments of the present disclosure provided in conjunction with the accompanying drawings is not intended to limit the scope of the present disclosure claimed for protection, but merely represents selected embodiments of the present disclosure. Based on the embodiments in the present disclosure, all other embodiments obtained by ordinary technicians in the field without creative work are within the scope of protection of the present disclosure.
[0061] Unless otherwise defined in the context, the singular includes the plural. Throughout the specification, the terms "comprising", "having", etc. are used herein to specify the presence of the features, numbers, steps, operations, elements, parts or combinations thereof, but do not exclude the presence or addition of one or more other features, numbers, steps, operations, elements, parts or combinations thereof.
[0062] In addition, even though terms including ordinal numbers such as "first," "second," etc. may be used to describe various components, these components are not limited by these terms, and these terms are only used to distinguish one element from other elements. For example, a first component may be referred to as a second component, and similarly, a second component may be referred to as a first component without departing from the scope of the present disclosure.
[0063] In the description of the present disclosure, it should be understood that the terms "upper", "lower", "left", "right", "inner", "outer", etc. indicate directions or positional relationships based on the directions or positional relationships shown in the accompanying drawings, or the directions or positional relationships in which the disclosed product is usually placed when in use, or the directions or positional relationships commonly understood by those skilled in the art, which are only for the convenience of describing the present disclosure and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific direction, be constructed and operated in a specific direction, and therefore cannot be understood as a limitation on the present disclosure. As used herein and in the claims, the directional terms "proximal" or "proximal end" refer to the direction close to the medical staff operating the drug delivery device or the direction away from the drug discharge needle of the drug delivery device and the end in this direction, while "distal" or "distal end" indicates the direction opposite to the "proximal", pointing to the direction in which the drug is administered, or the end indicated by the distal direction.
[0064] Figure 1 shows a longitudinal cross-sectional view of a drug delivery device according to an embodiment of the present disclosure, wherein a needle replacement element 13 is mounted on a cartridge 1; Figure 2 Shows Figure 1 A longitudinal cross-sectional reference diagram of a drug delivery device, wherein the needle replacement element 13 is replaced by a needle 14; Figure 3 Shows Figure 1 An exploded perspective view of a drug delivery device of FIG. 1 , which does not show the needle replacement element 13 or the needle 14 .
[0065] like Figure 1-Figure 3 As shown, the drug delivery device basically includes a housing, a cover 5, a cartridge 1, a push rod 4, an exhaust button 7, an injection spring 11, a trigger button 8, a sliding ejection member 9, a retaining element 6, a force unloading ring 10 and a force unloading spring 12. In addition, the drug delivery device also includes a needle replacement element 13 or a needle 14 that can be replaced with each other, both of which can be installed at the distal end of the cartridge 1, for example, by a threaded connection. Among them, the cartridge 1 is arranged at the distal side of the housing and can be connected with the installed needle 14 so that the drug in the cartridge 1 can be discharged by the push of the push rod 4. The exhaust button 7 is arranged at the proximal side of the housing, which is used to discharge the air in the cartridge before the drug is injected to ensure the dosage accuracy of the injection. In addition, the exhaust process simultaneously compresses the injection spring 11 to store energy for the subsequent drug injection, and after the trigger button 8 is triggered, the injection spring 11 pushes the push rod 4 to the distal side, and the drug is discharged to the target part of the patient through the needle 14. In order to further improve the accuracy of injection dosage, a post-exhaust unloading component and / or a post-injection unloading component are respectively provided so as to promptly retract the push rod 4 proximally to prevent more than the expected dose of the drug from being discharged from the cartridge, which is particularly important for injecting drugs with higher viscosity.
[0066] The housing is cylindrical, but the specific shape of the housing is not limited. The housing is provided with a space for installing the cartridge 1, and the cartridge 1 is installed in the space, and the cartridge 1 has a longitudinal axis and a hollow containing space 101 for loading the medicine. In the present embodiment, the drug delivery device is a preloaded drug delivery device. In other words, the hollow containing space 101 of the cartridge 1 is preloaded with the medicine to be administered. The user can operate the drug delivery device to discharge the air in the hollow containing space 101, pierce the needle 14 into the target site, and quantitatively discharge the medicine from the hollow containing space 101 to inject into the target site. The target site may include, for example, the posterior end of the eye, under the conjunctiva, around the eye, anterior chamber, in the vitreous body, in the choroidal cavity, sclera, subcutaneous, in the muscle or intradermal, etc.
[0067] The housing comprises a first half housing 2 and a second half housing 3 joined together in the longitudinal direction, and has a housing proximal opening at the proximal end, a housing distal opening at the distal end, and a housing lateral opening at the peripheral wall of the housing, which connects the proximal end and the distal end of the housing. The cartridge 1, the push rod 4, the injection spring 11, the sliding ejection member 9, the retaining element 6, the unloading ring 10, and the unloading spring 12 are all completely contained in the housing, and the exhaust button 7 and the trigger button 8 are partially contained in the housing and partially exposed outside the housing. The exhaust button 7 partially extends proximally to the outside of the housing via the proximal opening of the housing for user operation. The trigger button 8 is arranged at the lateral opening of the peripheral wall of the housing and protrudes outside the peripheral wall for user operation. The distal end portion of the cartridge 1 can be exposed via the distal opening of the housing, and the needle replacement element 13 or the needle 14 can be installed to the cartridge 1 via the distal opening of the housing. The cover 5 covers the distal end of the housing to close the distal opening of the housing. In this example, the first half shell 2 and the second half shell 3 are joined together along a plane including the longitudinal axis, but the present disclosure does not limit the joining method and joining position of the first half shell 2 and the second half shell 3 .
[0068] Figure 4 Shows Figure 1 A perspective view of the push rod 4 of the drug delivery device shown. Figure 4 As shown, the push rod 4 is in the shape of an elongated rod, including a push rod proximal end, a push rod distal end, and a rod body extending between the proximal end and the distal end, and a radial flange 405 is provided on the rod body between the push rod proximal end and the push rod distal end. Thus, the push rod 4 is composed of a first push rod section 401 close to the push rod proximal end, a third push rod section 403 close to the push rod distal end, and a second push rod section 402 between the first push rod section 401 and the third push rod section 403. The radial flange 405 is provided between the second push rod section 402 and the third push rod section 403. In addition, the push rod 4 also includes a push rod arm 404 radially protruding on the third push rod section 403 at the distal side of the radial flange 405. There are two push rod arms 404, for example, which extend in opposite directions in the radial direction, but the present application is not limited thereto.
[0069] Figure 5A and Figure 5B They are shown respectively Figure 1 A three-dimensional view of the exhaust button 7 of the drug delivery device shown. Figure 5A and Figure 5B As shown, the exhaust button 7 includes a first cylindrical wall 702, a second cylindrical wall 701 disposed in the first cylindrical wall 702, and a button proximal wall 709 (see Figure 1 In addition, the exhaust button 7 further includes a matching protrusion 706 disposed on the inner side of the first cylindrical wall 702, a third elastic arm 703 connected to the first cylindrical wall 702 and extending in the circumferential direction, a guide protrusion 704 disposed on the outer surface of the first cylindrical wall 702 and extending in the axial direction, and an avoidance notch 705 disposed on the proximal side of the guide protrusion 704.
[0070] Figure 6 Shows Figure 1 A three-dimensional view of the retaining element 6 of the drug delivery device shown. Figure 6 As shown, the retaining element 6 comprises a retaining element body 602, two first elastic arms 601 arranged diametrically opposite to each other, and two second elastic arms 603 arranged diametrically opposite to each other. The retaining element body 602 comprises a housing mating section 6021, a push mating section 6022 extending proximally from the housing mating section 6021, and a first accommodation space 6025 penetrating the retaining element body 602, in which the injection spring 11 is accommodated. The first elastic arm 601 extends distally from the retaining element body 602 in the axial direction, and the second elastic arm 603 is connected to the housing mating section 6021 of the retaining element body 602, extends proximally, and is laterally deflected outward from the retaining element body 602 in a free state. Figure 7 Shows Figure 1 A three-dimensional view of the exhaust button 7 of the drug delivery device and the retaining element 6 assembled to the exhaust button 7. Figure 7 As shown, the push-fit section 6022 of the retaining element 6 is inserted into the exhaust button 7 to be assembled to the exhaust button 7.
[0071] Figure 8 Shows Figure 1 The three-dimensional view of the sliding ejection member 9 of the drug delivery device shown. Figure 8 As shown, the sliding ejection member 9 includes a first ejection main body 901 and a second ejection main body 902 extending proximally from the first ejection main body 901. The second ejection main body 902 includes a second accommodating space 9023 and a cylindrical support body 9024 extending from the proximal end surface of the sliding ejection member 9 toward the distal end into the second accommodating space 9023, and the unloading spring 12 is accommodated in the second accommodating space.
[0072] Fig. 9 Shows Figure 1 A perspective view of the force-relieving ring 10 of the drug delivery device is shown. Fig.10 Shows Figure 1 The sliding ejection member 9 of the drug delivery device shown in FIG. Figure 8 , Fig. 9 and Fig.10 As shown, the unloading ring 10 includes an annular unloading ring body 1002 and a stepped blocking portion 1001 extending proximally from the unloading ring body 1002. The unloading ring body 1002 of the unloading ring 10 is sleeved on the cylindrical support body 9024 and the blocking portion 1001 extends from the proximal end of the support body 9024. The unloading ring 10 is configured to be axially slidable relative to the sliding ejection member 9, but cannot rotate. For example, the outer flat surface 1003 of the unloading ring body 1002 cooperates with the inner flat surface 9025 on the inner side wall of the second ejection main body 902 of the sliding ejection member 9, so that the unloading ring 10 is axially slidable relative to the sliding ejection member 9, but cannot rotate.
[0073] Fig.11 Shows Figure 1 A three-dimensional view of the trigger button 8 of the drug delivery device shown. Fig.11 As shown, the trigger button 8 includes a trigger limiting portion 801 located at two ends respectively, two fourth elastic arms 802 extending to both sides, and a pivot shaft 803 between the two ends.
[0074] Fig. 12A and Fig. 12B They are shown respectively Figure 1 A three-dimensional view of the first half shell 2 and the second half shell 3 of the drug delivery device shown. The first half shell 2 and the second half shell 3 are engaged with each other, for example, by snap-fitting, adhesive bonding or fastening with fasteners. The first half shell 2 and the second half shell 3 have shaft receiving holes 208 and 308 at the lateral openings of the shells, respectively, for receiving the pivot shaft 803 of the trigger button 8 so that the trigger button 8 can be pivotally mounted to the shell. The first half shell 2 and the second half shell 3 also each include a first limiting guide 206, 306 and a second limiting guide 207, 307 protruding inwardly. The first limiting guide 206, 306 is in contact with a first shape-fitting portion 604 (see FIG. 6 ) provided on the retaining element 6. Figure 6 ) to guide the axial sliding of the retaining element 6 in the housing. The second limiting guide 207, 307 cooperates with the second shape matching portion 904 (see FIG. 1 ) provided on the sliding ejection member 9. Figure 8 ) cooperate to guide the axial sliding of the sliding ejection member 9 in the housing. For example, the first limiting guide member 206, 306 and the second limiting guide member 207, 307 can extend substantially in the axial direction.
[0075] return Figure 1 and Figure 2 , the exhaust button 7 is mounted on the push rod proximal end of the push rod 4. At least a portion of the first push rod section 401 of the push rod 4 is inserted into the second cylindrical wall 701 of the exhaust button 7. The push-fit section 6022 of the retaining element 6 is inserted into the space formed between the first cylindrical wall 702 and the second cylindrical wall 701 of the exhaust button 7, so that the second cylindrical wall 701 passes through the middle opening formed in the proximal end wall of the push-fit section 6022 and enters the first accommodating space 6025 of the retaining element 6. The second push rod section 402 of the push rod 4 extends through the first accommodating space 6025. The injection spring 11 is mounted on the push rod 4, which is at least partially arranged around the second push rod section 402. The distal end of the injection spring 11 abuts against the radial flange 405 of the push rod 4, and the proximal end of the injection spring 11 abuts against the distal end surface of the proximal end wall 6024 of the retaining element 6 from the distal side. The push rod arm 404 of the push rod 4 abuts against the proximal end surface of the sliding ejection member 9 from the distal side (see Fig.17 ), the proximal end surface is used as the pushing surface 9021. The unloading ring 10 and the unloading spring 12 are accommodated in the second accommodating space 9023 of the sliding ejection member 9. The unloading ring body 1002 of the unloading ring 10 is sleeved on the cylindrical support body 9024 of the sliding ejection member 9 (see Fig. 9 and Fig.10 ). The unloading spring 12 at least partially surrounds the cylindrical support body 9024, and its distal end abuts against the second housing limit portion 202, 302 of the housing, and its proximal end abuts against the unloading ring body 1002 of the unloading ring 10. The first ejection body portion 901 of the sliding ejection member 9 is arranged around the cartridge 1, and has a lateral opening 903, and the trigger limiting portion 801 of the trigger button 8 can be inserted into the lateral opening 903 to releasably limit the axial movement of the sliding ejection member 9 to the distal side. The third push rod section 403 of the push rod 4 is inserted into the hollow accommodating space 101 of the cartridge 1 through the sliding ejection member 9 to define a drug accommodating space with a variable volume. The volume of the drug accommodating space is changed by the axial movement of the push rod 4 to achieve exhaust and drug administration. A rubber plug is provided at the distal end of the push rod 4 to seal the drug accommodating space.
[0076] When using drugs, especially drugs with high viscosity, the push rod 4 may cause a wake problem when being pushed distally to discharge air and / or drugs, that is, due to the inertia and viscosity of the drugs, more drugs than the expected dose are discharged from the cartridge 1, which makes it impossible to achieve accurate drug delivery. The drug delivery device of the embodiment of the present disclosure includes a first unloading component and a second unloading component, and the unloading operation after exhausting and after drug delivery is allowed to be achieved through the first unloading component and the second unloading component, that is, the push rod 4 moves a predetermined distance distally and then moves a unloading distance less than the predetermined distance proximally. The unloading operation can solve the wake problem, thereby achieving more accurate drug delivery. Therefore, the push rod 4 can be in the initial position, the exhaust position moving distally from the initial position to exhaust the air in the hollow accommodating space 101, the first unloading position moving proximally from the exhaust position to unload, the drug delivery position moving further distally from the first unloading position to discharge the drug in the hollow accommodating space 101, and the second unloading position moving proximally from the drug delivery position to unload. When the push rod 4 is in the initial position, the exhaust position, the first unloading position, the dosing position and the second unloading position, the drug containing space has an initial volume, a volume after exhaust, a first unloading volume, a volume after dosing and a second unloading volume, respectively, wherein the initial volume, the first unloading volume, the volume after exhaust, the second unloading volume and the volume after dosing decrease in sequence.
[0077] Figure 1 and Figure 2 The push rod 4 of the drug delivery device is in the initial position. Figure 13-16B They are shown respectively Figure 1 Another longitudinal cross-sectional view of the drug delivery device shown, wherein Fig.13 The push rod of the drug delivery device is in the exhaust position. Fig.14 The push rod of the drug delivery device is in the first force-releasing position, Fig.15A and Fig. 15B The push rod of the drug delivery device in the embodiment is in the drug delivery position, and Fig.16A and Fig. 16B The push rod of the drug delivery device is in the second unloading position. Fig.17 Shows Figure 1 A partially cutaway perspective view of the drug delivery device shown, Fig.18 Shows Fig.17 A partial enlarged view of Fig.19 Shows Figure 1 The longitudinal cross-sectional view of the drug delivery device shown in FIG. Fig. 20 Shows Fig.19 A partial enlarged view of Fig.17 and Fig.18 The push rod 4 of the drug delivery device is in the exhaust position, Fig.19 and Fig. 20 The push rod 4 of the drug delivery device is in the first unloading position.
[0078] like Figure 1 , Figure 2 and Fig.13 As shown, when performing the exhaust operation, the exhaust button 7 is pressed and moves axially to the distal side. When the exhaust button 7 moves to the distal side, the second cylindrical wall 701 abuts against the step surface 4012 toward the proximal side formed between the first push rod section 401 and the second push rod section 402 of the push rod 4 after moving a predetermined distance so that the push rod 4 is pushed to the exhaust position from the initial position to the distal side. Therefore, the volume of the medicine accommodating space of the cartridge 1 is reduced. At this time, the drug delivery device is positioned so that the needle 14 is upward relative to the direction of gravity, to discharge the air in the medicine accommodating space. In addition, when moving to the distal side, the push rod 4 then pushes the sliding ejection member 9 to the distal side. When the push rod 4 moves to the exhaust position, the trigger button 8 abuts against the sliding ejection member 9 from the distal side to releasably limit the sliding ejection member 9 and the push rod 4 to move further to the distal side. Specifically, the trigger limiting portion 801 of the trigger button 8 at its proximal end is inserted into the lateral opening 903 provided in the side wall of the first ejection main body portion 901 of the sliding ejection member 9, and the sliding ejection member 9 and the push rod 4 are releasably restricted from moving distally by abutting against the inner wall of the lateral opening 903 from the distal side. The fourth elastic arm 802 of the trigger button 8 abuts against the sliding ejection member 9 to keep the trigger limiting portion 801 of the trigger button 8 inserted.
[0079] When the exhaust button 7 moves toward the distal axis, the retaining element 6 moves distally together with the exhaust button 7 and compresses the injection spring 11. Specifically, the exhaust button 7 also includes a plurality of radial ribs 707 located at the proximal end in the space between the first cylindrical wall 702 and the second cylindrical wall 701 and extending radially from the first cylindrical wall 702 to the second cylindrical wall 701. When the exhaust button 7 moves toward the distal axis, the plurality of radial ribs 707 abut against the proximal end surface of the proximal end wall 6024 of the retaining element 6 from the proximal side to push the retaining element 6 distally. Since the exhaust button 7 abuts against the push rod 4 to move the push rod 4 distally only after moving distally a predetermined distance together with the retaining element 6, the distance that the push rod 4 moves distally is less than the distance that the retaining element 6 moves distally, which causes the injection spring 11 to be compressed, thereby storing energy. When the retaining element 6 moves distally, the second elastic arm 603 of the retaining element 6 moves from the proximal side of the first shell limiting portion 201, 301 of the shell to the distal side of the first shell limiting portion 201, 301 through elastic deformation, so that the first shell limiting portion 201, 301 limits the retaining element 6 from moving proximally to maintain the position of the retaining element 6 and maintain the compression of the injection spring 11.
[0080] like Fig.13 and Fig.14As shown, when viewed from the proximal side to the distal side along the longitudinal axis, the exhaust button 7 is rotated clockwise to achieve the unloading operation after exhausting, that is, the push rod 4 is retracted after moving distally to exhaust to avoid the drug from being unexpectedly discharged from the cartridge 1. The first unloading assembly is used to unload the force. The first unloading assembly is configured to cause the push rod 4 to move proximally during the rotation of the exhaust button 7. In the present embodiment, the first unloading assembly includes a push surface 9021 of the sliding ejection member 9. Fig.10 , Fig.17 and Fig.18 The push surface 9021 is shown more clearly. Fig.17 and Fig.18 As shown, the proximal push surface 9021 of sliding ejection member 9 can be specifically formed as the inclined surface tilted in the circumferential direction or the sloped surface of spiral rise.Certainly push surface 9021 of the present invention is not limited to this shape, for example, can also be arcuate or other curved surface shapes, as long as can when push rod arm 404 slides along push surface 9021, this push rod arm 404 can drive push rod 4 to move axially to the proximal side simultaneously, and its specific shape can be not limited.In the exhaust position, the push rod arm 404 of push rod 4 abuts against the proximal push surface 9021 of sliding ejection member 9.The rotation of exhaust button 7 causes push rod arm 404 to slide on proximal push surface 9021, so that push rod 4 is retracted to the first unloading position from the exhaust position towards the proximal side. Fig.19 and Fig. 20 The proximal push surface 9021 and the push rod arm 404 of the push rod 4 at the first unloading position are shown. In addition, the proximal push surface 9021 also has a distally concave retaining recess 9022 (such as Fig.10 and Fig. 20 As shown in FIG. 1 , when the exhaust button 7 is rotated clockwise, the push rod arm 404 slides on the proximal push surface 9021 and enters the retaining recess 9022 to maintain its circumferential position.
[0081] The first push rod section 401 of the push rod 4 is inserted into the second cylindrical wall 701 of the exhaust button 7. The outer flat surface 4011 (such as Figure 4 ) and the inner flat surface 7011 of the second cylindrical wall 701 (as shown Figure 5B As shown in the figure), the push rod 4 rotates with the exhaust button 7 and can move axially relative to the exhaust button 7. Figure 6 As shown, a matching recess 6023 extending in a spiral shape is provided on the outer circumference of the retaining element body 602 of the retaining element 6. Figure 5A and Figure 5BAs shown, a matching protrusion 706 is provided on the inner side surface of the first cylindrical wall 702 of the exhaust button 7. The push-fit section 6022 of the retaining element 6 is inserted into the first cylindrical wall 702, so that the matching protrusion 706 is accommodated in the matching recess 6023. In this way, when the exhaust button 7 rotates, the matching protrusion 706 moves along the spirally extending matching recess 6023, so that the exhaust button 7 moves proximally in the axial direction. The rise angle of the matching recess 6023 can be greater than the rise angle of the proximal push surface 9021 so that the distance of the exhaust button 7 moving axially toward the proximal side is greater than the push rod 4, so as to avoid the exhaust button 7 interfering with the movement of the push rod 4 toward the proximal side.
[0082] like Fig.14 , Fig.15A and Fig. 15B As shown, the trigger button 8 is operated to release the limit of the trigger button 8 on the sliding ejection member 9, thereby activating the drug administration operation. Specifically, the trigger button 8 is released by pressing the distal end of the trigger button 8. When the distal end of the trigger button 8 is pressed, the fourth elastic arm 802 of the trigger button 8 is deformed to allow the trigger button 8 to pivot around the pivot axis 803, so that the trigger limiting portion 801 of the trigger button 8 leaves the sliding ejection member 9, releasing the blockage of the sliding ejection member 9. In this way, the sliding ejection member 9 moves distally, and the push rod 4 moves axially from the first unloading position to the drug administration position distally under the action of the injection spring 11, and the injection spring 11 is compressed during exhaust and the stored energy is released. At this time, the needle 14 has been inserted into the target site, and the volume of the drug accommodating space is reduced to discharge the drug from the needle 14 to the target site.
[0083] After administration, the second unloading component is used to unload the force to prevent excess medicine from being undesirably discharged from the cartridge 1. Fig.15A , Fig. 15B , Fig.16A and Fig. 16B As shown, when the push rod 4 moves to the dosing position (see Fig.15A and Fig. 15B ), the second unloading assembly is actuated in response to the push rod 4 moving distally from the first unloading position to the medication position by a predetermined distance, so that the push rod 4 moves proximally to achieve a second unloading operation, that is, the push rod 4 retracts proximally to the second unloading position after moving distally to medication (see Fig.16A and Fig. 16B The second unloading assembly includes an unloading ring 10 sleeved on the sliding ejection member 9, an unloading spring 12 for biasing the unloading ring 10 toward the proximal side, and a first elastic arm 601 of the retaining element 6 extending toward the distal side.
[0084] Return to reference Figure 2 and Fig.13In the process of pressing the exhaust button 7, the retaining element 6 moves distally together with the exhaust button 7, and the retaining element 6 further pushes the unloading ring 10 distally through its first elastic arm 601 to compress the unloading spring 12, so that the unloading spring 12 stores energy. The first elastic arm 601 is releasably pressed against the stepped blocking portion 1001 of the unloading ring 10 from the proximal side to block the unloading ring 10 from moving proximally.
[0085] like Fig.15A , Fig. 15B , Fig.16A and Fig. 16B As shown, when the push rod 4 moves from the first unloading position to the dosing position (see Fig.15A and Fig. 15B ), the first elastic arm 601 is released from blocking the unloading ring 10. Therefore, the energy stored in the unloading spring 12 due to compression is released, and the push rod 4 is pushed axially to the proximal side through the unloading ring 10 to move to the second unloading position (see Fig.16A and Fig. 16B ). Specifically, Fig.19 and Fig. 20 As shown, after the exhaust button 7 drives the push rod 4 to rotate around the longitudinal axis so that the push rod 4 moves axially to the first unloading position, the push rod arm 404 is accommodated in the retaining recess 9022. When the push rod 4 moves from the first unloading position to the dosing position, the push rod arm 404 moves the blocking end 6011 of the first elastic arm 601 laterally away from the blocking portion 1001 of the unloading ring 10 during the process of distal movement, thereby releasing the blocking of the unloading ring 10. By appropriately setting the strength of the injection spring 11 and the unloading spring 12, a predetermined dose of medicine can be applied.
[0086] like Fig. 20 As shown, the blocking end 6011 of the first elastic arm 601 has a distal end surface 6012 facing the distal side and a first inclined surface 6013, a second inclined surface 6014 and a third inclined surface 6015 inclined relative to the axial direction in sequence from the distal side to the proximal side. The first inclined surface 6013 and the second inclined surface 6014 define a blocking recess 6016 concave in the lateral direction (see Figure 6 ), the second inclined surface 6014 and the third inclined surface 6015 define a blocking protrusion 6017 protruding in the lateral direction (see Figure 6). The inclination angle of the first inclined surface 6013 is smaller than the inclination angle of the second inclined surface 6014. The blocking portion 1001 of the unloading ring 10 has a stepped end surface, which has a first step-shaped protrusion 1003 and a second step-shaped protrusion 1004 in sequence in the axial direction from the distal side to the proximal side. The distal end surface 6012 abuts against the proximal end surface of the first step-shaped protrusion 1003, the second step-shaped protrusion 1004 abuts in the blocking recess 6016, and the distal end surface of the second step-shaped protrusion 1004 abuts against the blocking protrusion 6017. When the trigger button 8 is triggered and the push rod 4 moves to the dosing position, the third inclined surface 6015 is arranged on the moving path of the push rod arm 404, and the push rod arm 404 pushes the first elastic arm 601 to deflect in the lateral direction perpendicular to the axial direction via the third inclined surface 6015. The shapes of the blocking portion 1001 of the unloading ring 10 and the blocking end portion 6011 of the first elastic arm 601 allow the first elastic arm 601 to be reliably and smoothly deflected to move the push rod 4 to the second unloading position.
[0087] In addition, the first elastic arm 601 further includes an anti-deviating portion 6018, which is used to cooperate with the sliding ejection member 9 to prevent the first elastic arm 601 from accidentally releasing the blocking of the unloading ring 10 before the push rod 4 moves to the dosing position. Figure 6 and Fig.10 , Fig. 20 , the anti-deviation portion 6018 is arranged on the proximal side of the blocking end portion 6011 and protrudes in the lateral direction where the first elastic arm 601 is deviated by the push rod arm 404. Before the push rod 4 moves to the dosing position, the anti-deviation matching portion 9026 of the sliding ejection member 9 is aligned with the anti-deviation portion 6018 in the lateral direction to block the deflection of the first elastic arm 601. After the push rod 4 moves to the dosing position, the anti-deviation matching portion 9026 of the sliding ejection member 9 moves axially away from the anti-deviation portion 6018 to release the blocking of the first elastic arm 601.
[0088] Fig.21 The image is shown taken at the guide protrusion 704 of the exhaust button 7 before the exhaust button 7 is pressed. Figure 1 The transverse cross-sectional reference diagram of the drug delivery device shown, Fig. 22 The image is taken at the guide protrusion 704 of the exhaust button 7 after the exhaust button 7 is pressed and before the exhaust button 7 is rotated. Figure 1 The transverse cross-sectional reference diagram of the drug delivery device shown, Fig.23 The image taken at the guide protrusion 704 of the exhaust button 7 after the exhaust button 7 is rotated is shown. Figure 1 The transverse cross-sectional view of the drug delivery device shown in FIG. Fig.21As shown, before pressing the exhaust button 7, the guide protrusion 704 of the exhaust button 7 is positioned in the advancement guide groove between the third shell stop portion 203 of the first half shell 2 and the fourth shell stop portion 304 of the second half shell 3, so that the exhaust button 7 can slide axially but cannot rotate. The third shell stop portion 203 and the fourth shell stop portion 304 extend in the axial direction and the lateral direction and protrude inward. A portion of the third shell stop portion 203 is opposite and spaced from the fourth shell stop portion 304 in the circumferential direction (or lateral direction) to define the advancement guide groove, and the third shell stop portion 203 extends distally in the axial direction beyond the fourth shell stop portion 304. As shown in FIG. Fig. 22 As shown, after pressing the exhaust button 7, the avoidance notch 705 (see Figure 5A ) is aligned with the fourth housing stopper 304 in the circumferential direction, and the guide protrusion 704 of the exhaust button 7 is aligned with the third housing stopper 203 in the circumferential direction, so that the exhaust button 7 can only rotate in the unloading rotation direction for the first unloading operation and cannot rotate in the reverse direction. The unloading rotation direction is the rotation direction of the exhaust button in the unloading operation after exhausting. Fig.23 As shown, after the exhaust button 7 is rotated, the third elastic arm 703 extending circumferentially in the unloading rotation direction passes over the third housing limit portion 203 in the circumferential direction, so that the third housing limit portion 203 prevents the exhaust button 7 from rotating back. In addition, the guide protrusion 704 is rotated to be adjacent to the fifth housing limit portion 305, and is blocked by the fifth housing limit portion 305 from continuing to rotate. The fifth housing limit portion 305 is circumferentially spaced from the third housing limit portion 203 and the fourth housing limit portion 304 in the unloading rotation direction of the exhaust button 7, and protrudes inward. The cooperation between the exhaust button 7 and each limit portion in the housing allows the drug delivery device to be reliably operated to avoid misoperation.
[0089] The present disclosure is not limited to the above embodiments, and various modifications, variations, substitutions or supplements may be made within the scope of the present disclosure. In addition, the shape, size, quantity and arrangement position of the constituent elements in the above embodiments are optional and not limited, as long as the present disclosure can be implemented.
[0090] For example, in the above-mentioned embodiment, the push rod 4 is driven to move distally in the axial direction by the axial movement of the exhaust button 7, and then the exhaust button 7 is rotated to allow the push rod 4 to move proximally. In other embodiments, the push rod 4 can be driven to move distally in the axial direction by the rotation of the exhaust button 7. For example, the rotation of the exhaust button 7 is converted into axial movement by the cooperation of the exhaust button 7 with the spiral guide in the housing to drive the push rod 4 to move in the axial direction. For example, the push rod 4 is rotated together with the exhaust button 7, and the rotation of the push rod 4 is converted into axial movement by the cooperation of the push rod 4 with the spiral guide in the element such as the housing or the cartridge 1. In addition, in other embodiments, the push rod 4 can be driven to move distally in the axial direction, or the push rod 4 can be allowed to move proximally, by other ways of movement of the exhaust button 7.
[0091] For example, in the above-mentioned embodiment, the drug delivery device includes both the first unloading assembly and the second unloading assembly. In other embodiments, the drug delivery device may include only one of the first unloading assembly and the second unloading assembly as needed. In this way, the drug delivery device can only implement a corresponding one of the first unloading operation after exhaust and the second unloading operation after drug delivery. In addition, in other embodiments, the first unloading assembly and the second unloading assembly may have other configurations.
[0092] For example, in the above-mentioned embodiment, the push surface 9021 of the sliding ejection member 9 is located at the proximal end, and the push rod arm 404 of the push rod 4 for abutting against the push surface 9021 protrudes radially outward. In other embodiments, the push surface 9021 may also be located at other positions, or the push rod 4 may abut against the push surface 9021 of the sliding ejection member 9 through the distal end surface of the radial flange 405.
[0093] Although in the above-mentioned embodiment, the cartridge 1 is installed in the shell before the half shells 2 and 3 are snapped together so as to be sold or sent to the user as a whole, the present invention is not limited to this. For example, in other embodiments, the shells 2 and 3 are designed to be detachable in the part where the cartridge is installed, so that the cartridge 1 can be inserted after the drug delivery device is fully assembled or when the drug delivery device is sold to a user, such as a medical staff, the medical staff can load an optional cartridge into the drug delivery device.
[0094] The scope of the present disclosure is not limited by the above-described embodiments but by the appended claims and their equivalents.
Claims
1. A drug delivery device, characterized in that: include: case; A cartridge, which is disposed in the housing and has a hollow containing space for loading a drug; A push rod, comprising a push rod distal end and a push rod proximal end, wherein the push rod distal end is accommodated in the hollow accommodation space of the cartridge and is movable relative to the cartridge in an axial direction; An exhaust assembly configured to cause the push rod to move distally relative to the cartridge in the axial direction, the exhaust assembly comprising an exhaust button mounted at the proximal end of the push rod; an injection assembly configured to cause the push rod to move distally relative to the cartridge in the axial direction, the injection assembly comprising an injection spring and a trigger button, the injection spring being mounted on the push rod, and the trigger button being disposed at the outer peripheral wall of the housing; as well as A force unloading assembly is configured to cause the push rod to move in a proximal direction opposite to the distal direction after the push rod is moved distally by the exhaust assembly and / or the injection assembly.
2. The drug delivery device according to claim 1, characterized in that: The exhaust button is configured to drive the push rod to move distally relative to the cartridge in the axial direction through a first movement.
3. The drug delivery device according to claim 2, characterized in that: The exhaust button is further configured to allow the push rod to move proximally relative to the cartridge through a second movement after the first movement; and The unloading assembly includes a first unloading assembly configured to cause the push rod to move proximally relative to the cartridge during a second movement of the exhaust button.
4. The drug delivery device according to claim 2, characterized in that: The first movement of the exhaust button is a distal axial movement.
5. The drug delivery device according to claim 3, characterized in that: The second movement of the exhaust button is a rotation about the longitudinal axis and a proximal axial movement.
6. The drug delivery device according to claim 2, characterized in that: The injection spring is configured to be compressed in response to the first movement of the exhaust button; and The trigger button is configured to be actuated to release the energy stored in the injection spring due to compression, so as to cause the push rod to move distally and discharge the medicine in the hollow accommodation space.
7. The drug delivery device according to claim 6, characterized in that: Also includes A sliding ejector is configured to releasably restrict the distal movement of the push rod, and the restriction is releasable by actuation of the firing button.
8. The drug delivery device according to claim 7, characterized in that: The push rod is driven by the exhaust button to move distally, thereby moving the sliding ejector distally, and the distal movement of the sliding ejector causes the trigger button to abut against the sliding ejector distally.
9. The drug delivery device according to claim 7, characterized in that: Also includes: A retaining element is at least partially fitted within the exhaust button to move distally with the exhaust button during a first movement of the exhaust button and compress the injection spring.
10. The drug delivery device according to claim 9, characterized in that: The housing has a first housing stopper protruding inwardly. The retaining element has a second resilient arm extending proximally; After the first movement of the exhaust button, the second elastic arm moves from the proximal side of the first shell limiting portion to the distal side of the first shell limiting portion through deformation, so that the first shell limiting portion limits the proximal movement of the retaining element.
11. The drug delivery device according to claim 9, characterized in that: The push rod proximal end of the push rod is inserted into the exhaust button, and the push rod further includes a radial flange arranged between the push rod proximal end and the push rod distal end, and the injection spring abuts between the proximal end surface of the radial flange and the retaining element.
12. The drug delivery device according to claim 11, characterized in that: The push rod is further formed with at least one push rod arm protruding radially on the distal side of the radial flange, the sliding ejection member has a pushing surface, and the push rod arm abuts against the pushing surface of the sliding ejection member.
13. The drug delivery device according to claim 12, characterized in that: The exhaust button is further configured to allow the push rod to move proximally relative to the cartridge through a second movement after the first movement; and The unloading assembly includes a first unloading assembly configured to cause the push rod to move proximally relative to the cartridge during the second movement of the exhaust button. The first unloading assembly includes the push surface of the sliding ejection member and the push rod arm, the second movement of the exhaust button causes the push rod to rotate, thereby causing the push rod arm to slide on the push surface, and the push surface is formed so that the push rod arm slides on the push surface, causing the push rod to move proximally relative to the cartridge.
14. The drug delivery device according to claim 13, characterized in that: The pushing surface is formed as an inclined surface inclined in the circumferential direction or a spirally ascending slope surface.
15. The drug delivery device according to claim 13, characterized in that: The second movement of the exhaust button comprises a rotation about the longitudinal axis in a force-releasing rotation direction, The proximal end of the push rod matches the shape of the exhaust button, so that the push rod can move in the axial direction relative to the exhaust button, but cannot rotate relatively, so that when the exhaust button rotates, the push rod is driven to rotate together.
16. The drug delivery device according to claim 15, characterized in that: The second movement of the exhaust button also includes a proximal axial movement, The retaining element comprises a retaining element body, an outer peripheral surface of which is provided with a matching recess extending in a spiral shape. The exhaust button has a cylindrical wall, and a matching protrusion is arranged on the inner side surface thereof. The retaining element body is fitted within the cylindrical wall of the exhaust button so that the mating protrusion is received in the mating recess to allow the exhaust button to be axially movable relative to the retaining element while rotating relative to the retaining element.
17. The drug delivery device according to claim 15, characterized in that: The housing has a third housing stopper protruding inwardly. The exhaust button has a third elastic arm extending circumferentially in a direction opposite to the unloading rotation direction. After the second movement of the exhaust button, the third elastic arm passes over the third housing limit portion in the circumferential direction, so that the third housing limit portion prevents the exhaust button from rotating back.
18. The drug delivery device according to claim 17, characterized in that The exhaust button further includes a guide protrusion extending in the axial direction and an avoidance notch on the proximal side of the guide protrusion; The third housing limiting portion extends in the axial direction and protrudes inwardly, The housing further comprises: a fourth housing stopper extending in the axial direction and protruding inwardly, and a fifth housing stopper protruding inwardly and circumferentially spaced from the third and fourth housing stoppers in the unloading rotation direction; The third housing stop portion extends distally beyond the fourth housing stop portion in the axial direction and is opposite to and spaced apart from the fourth housing stop portion in the circumferential direction in the direction opposite to the unloading rotation direction to define an advancement guide groove; Before the first movement of the exhaust button, the guide protrusion of the exhaust button is axially slidably arranged in the advancement guide groove so that the exhaust button cannot be rotated. After the first movement of the exhaust button, the avoidance notch of the exhaust button is aligned with the fourth shell limiting portion in the circumferential direction, and the guide protrusion of the exhaust button is aligned with the third shell limiting portion in the circumferential direction, so that the exhaust button can only rotate in the unloading rotation direction but cannot rotate in the opposite direction. The fifth housing limiting portion is located in the force-releasing rotation direction of the guide protrusion to prevent the guide protrusion from further rotating in the force-releasing rotation direction after the second movement of the exhaust button.
19. The drug delivery device according to any one of claims 1 to 18, characterized in that: The unloading assembly includes a second unloading assembly configured to be actuated in response to the push rod being moved distally by the injection assembly until the injection is completed, thereby causing the push rod to move proximally relative to the cartridge.
20. The drug delivery device according to any one of claims 11 to 18, characterized in that: The unloading assembly includes a second unloading assembly configured to be actuated in response to the push rod being moved distally by the injection assembly until the injection is completed, thereby causing the push rod to move proximally relative to the cartridge, The second unloading assembly includes an unloading ring sleeved on the sliding ejection member, a unloading spring for biasing the unloading ring toward the proximal side, and a first elastic arm extending distally of the retaining element, wherein the first elastic arm can releasably abut against the unloading ring from the distal side to prevent the unloading ring from moving proximally.
21. The drug delivery device according to claim 20, characterized in that The push rod is moved distally by the injection assembly so that the first elastic arm releases the blocking of the unloading ring, allowing the unloading ring to move proximally under the action of the unloading spring, and thereby the unloading ring pushes the push rod to move proximally.
22. The drug delivery device according to claim 21, characterized in that The push rod is further formed with a radially protruding push rod arm on the far side of the radial flange. During the distal movement of the push rod by the injection assembly, the push rod arm causes the first elastic arm to be laterally deflected to release the blocking of the unloading ring.
23. The drug delivery device according to claim 22, characterized in that The unloading ring includes a blocking portion extending proximally, and the first elastic arm is releasably abutted against the blocking portion of the unloading ring from the distal side.
24. The drug delivery device according to claim 23, characterized in that The blocking portion is formed in a step shape.
25. The drug delivery device according to claim 20, characterized in that When the retaining element moves distally during the first movement of the exhaust button, the unloading ring moves distally via the first elastic arm to compress the unloading spring.
